Know Cancer

or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
    Integris Cancer Institute of OK
    Oklahoma City, Oklahoma 73142
    Malignant Melanoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia
    Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliomatosis Cerebri, Gliosarcoma, Brainstem Glioma
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Solid Tumors, Ovarian Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Brain and Central Nervous System Tumors
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cancer
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Tissue From Young Patients With Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cancer
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Mercy Campus
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Lymphoma
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    University of Oklahoma Health Sciences Center Dept of OHSC
    Oklahoma City, Oklahoma 73104
    Renal Cell Carcinoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Neuroblastoma
    HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Brain and Central Nervous System Tumors
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Cancer
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    OMRF Multiple Sclerosis Center of Excellence
    Oklahoma City, Oklahoma
    Multiple Sclerosis, Relapsing-Remitting
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Prostate Cancer, Sexual Dysfunction
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Solid Tumors, Cancer
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    University of Oklahoma Health Sciences Center Univ OK HSC
    Oklahoma City, Oklahoma 73104
    Myelodysplastic Syndromes
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Mercy Physicians of Oklahoma-Lakeside
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Lymphoma
    Stem Cell Related Donor Safety Study
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Related Hematopoietic Stem Cell Donors
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Sarcoma
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Head and Neck Cancer
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
    Study of Blood Samples From Newborns With Down Syndrome
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Melanoma (Skin)
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Red Cell Storage Duration Study
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cardiac Surgery, Erythrocyte Transfusion
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Lymphoma, Lymphoproliferative Disorder
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Breast Cancer, Cardiac Toxicity
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Colorectal Cancer, Precancerous Condition
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Mercy Physicians of Oklahoma-Lakeside
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia, Lymphoma
    AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Pancreatic Cancer
    Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer